These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31043584)
41. Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma Ali R; Al-Kawaz A; Toss MS; Green AR; Miligy IM; Mesquita KA; Seedhouse C; Mirza S; Band V; Rakha EA; Madhusudan S Cancer Res; 2018 Dec; 78(24):6818-6827. PubMed ID: 30297533 [TBL] [Abstract][Full Text] [Related]
42. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines. Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020 [TBL] [Abstract][Full Text] [Related]
43. XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant. Persaud AK; Li J; Johnson JA; Seligson N; Sborov DW; Duah E; Cho YK; Wang D; Phelps MA; Hofmeister CC; Poi MJ Mol Carcinog; 2019 Dec; 58(12):2327-2339. PubMed ID: 31544312 [TBL] [Abstract][Full Text] [Related]
44. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer. Kala R; Shah HN; Martin SL; Tollefsbol TO BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286 [TBL] [Abstract][Full Text] [Related]
45. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation. Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449 [TBL] [Abstract][Full Text] [Related]
46. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
47. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis. Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875 [TBL] [Abstract][Full Text] [Related]
48. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388 [TBL] [Abstract][Full Text] [Related]
49. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy. García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907 [TBL] [Abstract][Full Text] [Related]
50. S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer. Huang Y; Hu K; Zhang S; Dong X; Yin Z; Meng R; Zhao Y; Dai X; Zhang T; Yang K; Liu L; Huang K; Shi S; Zhang Y; Chen J; Wu G; Xu S Theranostics; 2018; 8(5):1286-1300. PubMed ID: 29507620 [No Abstract] [Full Text] [Related]
51. Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. Kim HB; Lee SH; Um JH; Oh WK; Kim DW; Kang CD; Kim SH Oncotarget; 2015 Nov; 6(34):36202-18. PubMed ID: 26416354 [TBL] [Abstract][Full Text] [Related]
52. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Kojima K; Ohhashi R; Fujita Y; Hamada N; Akao Y; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2008 Aug; 373(3):423-8. PubMed ID: 18573234 [TBL] [Abstract][Full Text] [Related]
53. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells. Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424 [TBL] [Abstract][Full Text] [Related]
54. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells. Qiao Y; Zhang Y; Wang J Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582 [TBL] [Abstract][Full Text] [Related]
55. SIRT1 and gynecological malignancies (Review). Chen J; Chen H; Pan L Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834 [TBL] [Abstract][Full Text] [Related]
56. SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation. Prola A; Pires Da Silva J; Guilbert A; Lecru L; Piquereau J; Ribeiro M; Mateo P; Gressette M; Fortin D; Boursier C; Gallerne C; Caillard A; Samuel JL; François H; Sinclair DA; Eid P; Ventura-Clapier R; Garnier A; Lemaire C Cell Death Differ; 2017 Feb; 24(2):343-356. PubMed ID: 27911441 [TBL] [Abstract][Full Text] [Related]
57. Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance. Sourisseau T; Helissey C; Lefebvre C; Ponsonnailles F; Malka-Mahieu H; Olaussen KA; André F; Vagner S; Soria JC Cell Cycle; 2016; 15(2):295-302. PubMed ID: 26825230 [TBL] [Abstract][Full Text] [Related]
58. Domain specific interaction in the XRCC1-DNA polymerase beta complex. Marintchev A; Robertson A; Dimitriadis EK; Prasad R; Wilson SH; Mullen GP Nucleic Acids Res; 2000 May; 28(10):2049-59. PubMed ID: 10773072 [TBL] [Abstract][Full Text] [Related]
59. Putative E3 ubiquitin ligase of human rotavirus inhibits NF-κB activation by using molecular mimicry to target β-TrCP. Morelli M; Dennis AF; Patton JT mBio; 2015 Jan; 6(1):. PubMed ID: 25626907 [TBL] [Abstract][Full Text] [Related]